Phagenesis Ltd
Scott Grant has a diverse work experience spanning over multiple companies and roles. Scott began their career in 1985 as a Clinical Specialist and Territory Manager at Advanced Cardiovascular Systems. Scott later worked as a Regional Sales Manager at Advanced Cardiovascular Systems/Guidant from 1990 to 1993. From 1995 to 2000, they served as the Director of International Sales & Marketing at Perclose. Scott then joined Abbott in 2000 as the Director of Strategic Accounts. In 2003, they became the Vice President of Market Development & International at Emphasys Medical Inc. From 2009 to 2012, they worked at Broncus Technologies as the Vice President of Global Sales. Scott then served as the Vice President of International Business Development at NUVAIRA, Inc. from 2012 to 2015. From 2016 to 2018, they worked as a Principal at PSG Consulting. Most recently, Scott Grant held the position of Vice President of Market Development at Vascular Dynamics from 2018 to 2020. Scott currently holds two positions at Phagenesis Ltd since November 2020, serving as the Vice President of Therapy Development and the Vice President of Therapy Development US.
Scott Grant has a Bachelor of Science degree in Health Management Services from Indiana University School of Medicine. Scott also has a Bachelor of Science degree in Health Administration from the same institution.
This person is not in any offices
Phagenesis Ltd
1 followers
Phagenesis is developing a device for the treatment for dysphagia, the inability to swallow safely, that often accompanies stroke or other neuro-deficit diseases. The approach is to harness the brain's own capacity for relearning functions that have been lost through brain damage (via "neuroplasticity" or "corticalremapping"). Focusing initially on the care of stroke patients as they recover in hospital (acute care), Prof Shaheen Hamdy of the University of Manchester, UK, painstakingly devised a method of delivering electrical signals from the pharynx (throat) along nerve cells directly to the relevant parts of the brain. The results of his work have been published in top peer-reviewed scientific and medical journals, including The Lancet, the Nature group of publications, and Gastroenterology.